Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery
There is little scientific data concerning the use of negative pressure therapy after immediate breast reconstruction. That strategy of treatment-reconstruction has expanded increasingly since the last years. The current literature reports only 3 studies on the use of preventive negative pressure therapy in oncologic breast surgery. Moreover, all three are retrospective, case-control studies with serious limitations. The largest published series reports a reduction in the overall complication rate from 15.9%…
Conditions studied
Breast Cancer
About this study
There is little scientific data concerning the use of negative pressure therapy after immediate breast reconstruction. That strategy of treatment-reconstruction has expanded increasingly since the last years. The current literature reports only 3 studies on the use of preventive negative pressure therapy in oncologic breast surgery. Moreover, all three are retrospective, case-control studies with serious limitations. The largest published series reports a reduction in the overall complication rate from 15.9% to 8.5%, and a significant reduction in several criteria: infection, scar dehiscence and necrosis. However, the study presents significant biases, with non-comparable populations in terms of comorbidities, surgical procedure performed, inclusion periods (and therefore experience in performing oncological surgery). There was also a high probability of under-assessment or postponement of post-operative complications, which is typical of published retrospective surgical studies. The published results therefore strongly encourage further investigation of negative pressure therapy in oncological breast surgery.
Interventions
- Procedure: Negative pressure therapy (NPT) — Negative pressure therapy (NPT) involves placing the surface of a wound under a pressure lower than the ambient atmospheric pressure. To achieve this, a specially designed dressing is connected to a vacuum source and an exudate collection system.
- Procedure: Dressing — Fatty dressing or hydrocellular dressing
Primary outcomes
- Rate of patients experiencing postoperative wound healing complication (From baseline to 30 days after surgery)
Eligibility information
Study locations
- Centre Georges-François Leclerc, Dijon, Côte d'Or 21079 France
- Centre Hospitalier de Nîmes, Nîmes, GARD 30900 France
- Institut Bergonié, Bordeaux, Gironde 33076 France
- Centre Hospitalier de Montpellier, Montpellier, Hérault 34090 France
- Institut régional du Cancer de Montpellier, Montpellier, Hérault 34298 France
- Institut de Cancérologie de l'Ouest, Angers, Maine Et Loire 49055 France
- Centre Léon Bérard, Lyon, Rhône 69373 France
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-17.